Eytan Stein, MD
Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Eytan Stein, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:20 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06773208 · A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)Memorial Sloan Kettering Cancer Center · recruiting · Acute Myeloid Leukemia (AML) · principal investigator
- Ph1NCT05756777 · A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)Memorial Sloan Kettering Cancer Center · active not recruiting · Acute Myeloid Leukemia (AML) · principal investigator
- Ph1NCT05102370 · A Study of Enasidenib in People With Clonal Cytopenia of Undetermined SignificanceMemorial Sloan Kettering Cancer Center · completed · Clonal Cytopenia of Undetermined Significance, CCUS Clonal Cytopenia of Undetermined Significance · principal investigator
- Ph2NCT05024994 · A Study of E7820 in People With Bone Marrow (Myeloid) CancersMemorial Sloan Kettering Cancer Center · completed · Acute Myeloid Leukemia, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in acute myeloid leukemia.